133 results
8-K
EX-99.1
ACST
Acasti Pharma Inc - Ordinary Shares
27 Jun 24
Acasti Announces Achievement of 50% Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial
4:10pm
"forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, as amended, Section 27A
8-K
EX-99.1
ACST
Acasti Pharma Inc - Ordinary Shares
21 Jun 24
Acasti Announces Year-End 2024 Financial Results, Provides Business Update
8:00am
that are not statements of historical or current fact constitute "forward-looking statements" within the meaning of the U.S. Private Securities Litigation
8-K
EX-99.1
hdvvvk4o
1 Apr 24
Regulation FD Disclosure
8:00am
8-K
EX-99.1
pm3o131u
12 Feb 24
Acasti Announces Third Fiscal Quarter 2024 Financial Results and Business Highlights
8:00am
8-K
EX-99.1
p24tp m3f
13 Nov 23
Acasti Announces Second Quarter 2024 Financial Results and Business Highlights
12:00am
8-K
EX-99.1
wnb5ff 78ey
23 Oct 23
Acasti Announces Dosing of First Patient in GTX-104 STRIVE-ON Trial
4:30pm
8-K
EX-10.1
hiwcxxttub0a1jbrz7sg
23 Oct 23
Acasti Announces Dosing of First Patient in GTX-104 STRIVE-ON Trial
4:30pm
8-K
EX-10.1
dpbmk4rn
26 Sep 23
Acasti Announces $7.5 Million Private Placement Equity Financing
8:10am
8-K
EX-99.1
qup3g93iqn93z6h4mi5a
26 Sep 23
Acasti Announces $7.5 Million Private Placement Equity Financing
8:10am
8-K
EX-99.1
8a1y n3eq215vi4
11 Aug 23
Acasti Announces First Quarter 2024 Financial Results and Business Highlights
7:31am
8-K
EX-99.1
skkhd m6dasl
7 Jul 23
Acasti Pharma Announces 1-for-6 Reverse Stock Split
8:30am
8-K
EX-99.1
cek cxb3h
5 Jul 23
Other Events
4:00pm
8-K
EX-99.1
c28z1v
23 Jun 23
Acasti Pharma Reports Fiscal Year 2023 Operational Results
7:31am
8-K
EX-99.1
dw5gws3wsyd3fqckrd3
5 Apr 23
Acasti Announces Appointment of Prashant Kohli as CEO
5:00pm
8-K
EX-99.2
8fn ejnln3
5 Apr 23
Acasti Announces Appointment of Prashant Kohli as CEO
5:00pm